
Targeted Drug May Lower Odds for Breast Cancer’s Return in Some Patients
By Cara Murez HealthDay ReporterTUESDAY, June 6, 2023 (HealthDay News) — Here’s some good news for women with the most common type of breast cancer: Adding a targeted breast cancer drug to hormonal therapy reduced the risk of cancer returning by 25% for women with early-stage disease, a new clinical trial shows. Hormone-receptor (HR) positive/HER2 negative breast… […]